KalVista Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) N/A N/A N/A N/A N/A
    (estimated) €389.01M +32.1% €157.66M +96.9% 40.5% +0.13 pp N/A N/A
    (estimated) €294.58M +37.9% €80.08M -453.2% 27.2% +0.38 pp N/A N/A
    (estimated) €213.69M +109.5% -€22.67M -79.5% -10.6% +0.98 pp N/A N/A
    (estimated) €101.98M +∞% -€110.86M -29.2% -108.7% -1.1 pp N/A N/A
    €0.00 +NaN% -€156.47M +44.9% N/A -€130.42M +72.2% N/A
    €0.00 +NaN% -€108.02M +69.2% N/A -€75.73M +19.9% N/A
    €0.00 +NaN% -€63.85M +9.3% N/A -€63.17M -4.1% N/A
    €0.00 -100.0% -€58.44M +54.0% N/A -€65.85M +156.6% N/A
    €10.82M +0.0% -€37.95M +52.8% -350.6% -1.2 pp -€25.66M -32.5% -237.1% +1.1 pp
    €10.82M -21.3% -€24.83M +39.9% -229.4% -1.0 pp -€38.04M +26.4% -351.4% -1.3 pp
    €13.76M +92.1% -€17.76M +31.7% -129.1% +0.59 pp -€30.10M -394.4% -218.8% -3.6 pp
    €7.16M +458.1% -€13.48M -15.0% -188.3% +10 pp €10.22M -150.7% 142.8% +17 pp
    €1.28M -29.5% -€15.87M +62.7% -1,236.9% -7.0 pp -€20.17M +79.9% -1,572.3% -9.6 pp
    €1.82M +414.0% -€9.75M +101.4% -536.1% +8.3 pp -€11.21M +171.6% -616.3% +5.5 pp
    €353.97K -73.0% -€4.84M +176.6% -1,368.2% -12 pp -€4.13M +177.5% -1,166.3% -11 pp
    €1.31M -€1.75M -133.5% -€1.49M -113.4%

    Notifications